drugset / Trial / NCT00403416
Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy and safety of AEB071 in preventing acute rejections after kidney transplantation, when combined with tacrolimus for the first 3 months and with myfortic thereafter.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | mycophenolic acid | Small molecule | — | — |
| Subject | sotrastaurin | Small molecule | — | — |
Indications
No indication recorded.